(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Dr. Charles Bishop, CEO of OPKO Health Renal Division, to discuss the FDA’s approval of Rayaldee and the health issues surrounding chronic kidney disease

Meta to Spend Up to $27 Billion on Nebius AI Infrastructure
15:55

Adobe CEO to Step Down in Face of Investor Concerns Over AI
18:19

Dick’s Projects Sales Growth at Namesake Stores, Foot Locker
14:01